CA
NZ
UK
AU
IND
US
Twist Bioscience shares are trading sharply higher, up about 19.44 percent to $138.67 and touching a fresh 52-week high of $141.10 during the session, extending a multi-day rally. The advance began after the company's most recent quarterly report showed revenue up 23 percent year …
Eli Lilly shares are trading higher, up about 3.59 percent to $1,269.70 and trading near a 52-week high of $1,292.73, extending recent gains. The advance follows the company's expansion of its neuroscience pipeline, including acquiring global rights to AlzeCure Pharma's preclinical Alzheimer's disease candidate …
Merck shares are trading sharply higher, up about 11.05 percent to $150.10, marking the stock's best trading session since March 2009. The move follows this morning's announcement that intismeran autogene, an individualized mRNA-based cancer therapy jointly developed with Moderna, combined with Merck's KEYTRUDA, met …
Iovance Biotherapeutics shares are trading sharply higher, up about 9.89 percent to $7.73 and trading near a 52-week high of $7.85, extending a multi-day rally. The advance builds on the company's second-quarter earnings report released August 6, which showed revenue of $198.6 million, up …
Pfizer shares are trading sharply higher, up about 4.13 percent to $28.38, outperforming the broader healthcare sector as investors continue to digest the company's strong second-quarter results. Earnings per share of $0.77 beat consensus by $0.09, and revenue of $15.03 billion topped the $14.40 …
Absci shares are trading higher, up about 10.06 percent to $9.74, after the company's second-quarter earnings report highlighted a strengthened balance sheet with $201.1 million in cash following a $93.6 million capital raise that included a strategic investment from Eli Lilly. The improved cash …
Johnson & Johnson shares are trading modestly higher, up about 1.05 percent to $273.97 and near a 52-week high of $276.43, after the FDA granted De Novo authorization for the company's OTTAVA robotic surgical system for upper abdominal general surgery procedures. The authorization bolsters …
Thermo Fisher Scientific shares are trading sharply higher, up about 4.13 percent to $613.35 and hitting fresh highs near $620 during the session. The advance builds on July's beat-and-raise quarter, with earnings per share of $6.03 beating the $5.71 estimate and revenue of $11.99 …
AbbVie shares are trading higher, up about 1.84 percent to $263.69, gaining momentum asWall Streetsnapped a three-day slide with Treasury yields pulling back from multi-decade highs, easing pressure on rate-sensitive large-cap stocks. The advance comes as investors continue to digest the company's strong second-quarter …
● Alector jumped about 7.8% in August 2026, a bounce in a stock that has been battered by back-to-back clinical failures.
Please wait processing your request...